Folate Market Segmentation:
End-User Segment Analysis
Pharmaceuticals & nutraceuticals segment is expected to account for folate market share of around 50% by 2035. This growth of the segment is poised to be encouraged by the rising prevalence of cardiovascular disease. As per the World Health Organization, cardiovascular diseases (CVDs) are the major reason of death worldwide, taking about 17.9 million lives every year.
One of the main factors for this growing prevalence is the surging consumption of unhealthy food. Hence, the utilization of folate is growing in the pharmaceutical sector. Furthermore, one of the research projects in 2020 has indicated that the consumption of folate reduces the risk of heart attack by about 15%, whereas reduces the possibility of stroke by 23%.
Type Segment Analysis
The 5-MTHF calcium salt segment is projected to observe a notable rise in its revenue over the forecast period. This growth of the segment can be encouraged by the surging number of people suffering from anemia. For instance, in 2021, close to 2 billion population across the globe had anemia. This also indicates a rise of about 419 million cases over three decades. Anemia is usually caused due to the lack of red blood cells in the body which could be treated by 5-MTHF calcium salt.
However, the 5-MTHF glucosamine salt segment is also expected to observe growth in the market by 2035. This could be owing to rising government initiatives to provide the best medications to women during their pregnancy. Furthermore, this is also utilized significantly to treat infertility and hyperhomocysteinemia.
Our in-depth analysis of the folate market includes the following segments:
|
Type |
|
|
Source |
|
|
Form |
|
|
End-User |
|
